Gene · 6607
NIH grants1,484
NIH grants whose papers are about the gene, through NIH's grant-paper links.
541 to 560 of 1,484
Download this page as JSON| Grant | Title | SMN2 papers | Newest fiscal year |
|---|---|---|---|
| R01GM124486 | Single-nucleotide resolution mapping of allelic protein-RNA interactions and splicing-regulatory variants | 1 | 2021 |
| R01GM125632 | Computational epigenetics modeling of cell identity genes | 1 | 2021 |
| R01GM125871 | A Technique for Measuring Transcription Factor Activity | 1 | 2021 |
| R01GM126833 | Defining the Structural Mechanisms of RNP Complexes that Regulate Enterovirus Translation | 1 | 2021 |
| R01HG009318 | Novel algorithm development, user support and maintenance for STAR | 1 | 2021 |
| R01HL133254 | Role of S-nitrosylation in Transdifferentiation | 1 | 2021 |
| R01HL137223 | Analysis of RNA binding proteins directing hematopoietic stem cell fate | 1 | 2021 |
| R01HL140938 | Regulating fibrosis and growth through latent TGFbeta binding proteins | 1 | 2021 |
| R01MH094589 | Transcriptional regulation of neuronal identity and connectivity | 1 | 2021 |
| R01MH113005 | Revealing the transcriptomic basis of neuronal identity through functional meta-analysis | 1 | 2021 |
| R01MH115357 | Brain trajectories in ADHD | 1 | 2021 |
| R01MH115860 | Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1 | 1 | 2021 |
| R01NS081366 | GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA | 1 | 2021 |
| R01NS097903 | RNA Granules in Cerebellar Neurodegeneration | 1 | 2021 |
| R01NS100783 | Endogenous regulation of huntingtin expression as a therapeutic target for Huntington's disease | 1 | 2021 |
| R21NS118280 | MicroRNA site-blocking oligonucleotides as a novel therapy for neurodevelopmental disorders | 1 | 2021 |
| R21TR003184 | Development and validation of clinical outcome assessments in LGMD2A | 1 | 2021 |
| R25GM083270 | Advancing the Culture of Ph.D. Learning and Scholarship in Biology and Health Science | 1 | 2021 |
| R25GM122722 | RISE: A graduate training program to increase diversity in biomedical science | 1 | 2021 |
| R33NS110960 | High-throughput Screen for Discovery of Ciliary Neurotrophic Factor (CNTF) Receptor Agonists for the Treatment of Amyotrophic Lateral Sclerosis (ALS) | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/grants?page=28